The mummified bodies of Peruvians who died up to 1,000 years ago will yield up their secrets, thanks to a prestigious research project by the University of Huddersfield's Dr Stefano Vanin and two of his students in collaboration with the University of Pisa and the Ancient World Society.
[More]
Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.
[More]
L-carnitine significantly improves cardiac health in patients after a heart attack, say a multicenter team of investigators in a study published today in Mayo Clinic Proceedings.
[More]
Despite their greater life expectancy, the adults of today are less "metabolically" healthy than their counterparts of previous generations.
[More]
The obesity epidemic in America and its impact on musculoskeletal health, as well as related treatment outcomes and costs, was discussed during the AAOS Now forum, "Obesity, Orthopaedics and Outcomes," at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons at McCormick Place in Chicago.
[More]
Roche and Isis Pharmaceuticals, Inc today announced that they have formed an alliance to develop treatments for Huntington's disease based on Isis' antisense oligonucleotide technology.
[More]
AstraZeneca today announced top-line results of OSKIRA-1, a Phase 3 study to assess the efficacy and safety of fostamatinib, the first oral spleen tyrosine kinase inhibitor in development for rheumatoid arthritis.
[More]
One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation at the University of Washington revealed significant differences across the US.
[More]
Global population data spanning the years from 1900 to 2010 have enabled a research team from the Autonomous University of Madrid to predict that the number of people on Earth will stabilise around the middle of the century.
[More]
President Obama officially announced his new brain research initiative on Tuesday, with a pledge to put $100 million in his 2014 budget to support work at three federal agencies.
[More]
The Washington Post examines how the HIV and tuberculosis epidemics are affecting Russia, where "HIV/AIDS was the third-largest cause of premature death," according to recently released data in the Global Burden of Disease Study 2012.
[More]
Studies show "the profound impact of antiretroviral-therapy coverage at a population level" -- how wider coverage can increase life expectancy and reduce the risk of HIV infection.
[More]
Amid changing weather and water patterns worldwide and forecasts of more severe transformations to come, calls have been growing for the UN Security Council to include water issues on its agenda.
[More]
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world’s leading provider of diagnostic information services.
[More]
Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
[More]
Higher mortality rates among Americans younger than 50 are responsible for much of why life expectancy is lower in the United States than most of the world's most developed nations.
[More]
Research to set up an online system enabling doctors to access patients' health records from all across the European Union, has been launched.
[More]
The U.N. Development Programme on Thursday in Mexico City launched the Human Development Index 2013, which "combines measures of life expectancy, literacy, school enrollment and gross domestic product per capita," the U.N. News Centre reports.
[More]
GTx, Inc. today announced that the journal, The Lancet Oncology, has published online ahead of its April print edition the results from GTx's randomized, double-blind, placebo-controlled Phase 2 clinical trial of enobosarm to assess its effects on muscle wasting and physical function in patients with cancer.
[More]
At the same time, President Barack Obama appears to be harboring hopes of reaching a big deficit-reduction deal that could include some of the money-saving changes that Republicans favor. The idea worries some congressional Democrats.
[More]